Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$7.35 USD
+0.03 (0.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.34 -0.01 (-0.14%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 6/19/24 |
---|---|
Current Quarter | 0.03 |
EPS Last Quarter | -0.08 |
Last EPS Surprise | -300.00% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.11 |
Next Year | -0.11 |
EPS (TTM) | -0.15 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 40.85M | NA | 138.30M | 167.75M |
# of Estimates | 2 | NA | 2 | 2 |
High Estimate | 42.70M | NA | 139.60M | 175.00M |
Low Estimate | 39.00M | NA | 137.00M | 160.50M |
Year ago Sales | 39.80M | 37.73M | 149.27M | 138.30M |
Year over Year Growth Est. | 2.64% | NA | -7.35% | 21.29% |
Earnings Estimates
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03 | NA | -0.11 | -0.11 |
# of Estimates | 1 | NA | 1 | 1 |
Most Recent Consensus | 0.03 | NA | -0.11 | -0.11 |
High Estimate | 0.03 | NA | -0.11 | -0.11 |
Low Estimate | 0.03 | NA | -0.11 | -0.11 |
Year ago EPS | 0.05 | 0.00 | 0.16 | -0.11 |
Year over Year Growth Est. | -40.00% | NA | -168.75% | 0.00% |
Agreement - Estimate Revisions
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 0 | NA | 0 | 0 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 0 | NA | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Current | 0.03 | NA | -0.11 | -0.11 |
7 Days Ago | 0.03 | NA | -0.11 | -0.11 |
30 Days Ago | 0.03 | NA | -0.11 | -0.11 |
60 Days Ago | 0.03 | NA | 0.02 | 0.15 |
90 Days Ago | 0.03 | NA | 0.02 | 0.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (4/2024) |
Next Qtr (7/2024) |
Current Year (4/2024) |
Next Year (4/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.03 | NA | -0.11 | -0.11 |
Zacks Consensus Estimate | 0.03 | NA | -0.11 | -0.11 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Quarter Ending (4/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.08 | -0.12 | 0.00 | 0.05 | NA |
Estimate | -0.02 | -0.09 | -0.04 | -0.02 | NA |
Difference | -0.06 | -0.03 | 0.04 | 0.07 | 0.01 |
Surprise | -300.00% | -33.33% | 100.00% | 350.00% | 29.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more